IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Copernicus Capital Management, LLC

Q2 2021 Holdings

Filed 2021-08-16 | 11 holdings | $6.3K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Vertex Pharmaceuticals Inc(VRTX)COM92532F100$1.8K9,00028.6%
Fate Therapeutics Inc(FATE)COM31189P102$86810,00013.7%
Atara Biotherapeutics Inc(ATRAGBX)COM046513107$77850,00012.3%
Zentalis Pharmaceuticals Inc(ZNTL)COM98943L107$53210,0008.4%
Tcr2 Therapeutics IncCOM87808K106$49230,0007.8%
Horizon Therapeutics PUB LSHSG46188101$4685,0007.4%
Accolade Inc(ACCDEUR)COM00437E102$3807,0006.0%
Jazz Pharmaceuticals PLC(JAZZ)SHS USDG50871105$3552,0005.6%
Gritstone BIO Inc(2JQ)COM39868T105$32035,0005.0%
The Beauty Health Company(SKIN)COM CL A88331L108$16810,0002.6%
Arcus Biosciences Inc(RCUS)COM03969F109$16520,0002.6%